Table 2.
Association of SNPs in 4 chromosomal regions with lung cancer in four populations. Shown are the number of cases and controls (N), the frequencies of the effect allele (see Table 1) in cases and controls, the odds ratio and 95% confidence intervals (OR and 95%CI), the P value for the test of association (P). The results for Peripheral Arterial Disease are shown in Supplementary Table 4.
N | Freq | |||||
---|---|---|---|---|---|---|
|
||||||
Population | case | control | case | control | OR (95% CI) | P |
rs6474412-T, chromosome 8p11 | ||||||
Iceland | 839 | 36,606 | 0.784 | 0.770 | 1.08 (0.96, 1.22) | 0.19 |
Denver | 192 | 856 | 0.805 | 0.790 | 1.09 (0.83, 1.44) | 0.53 |
Spain | 351 | 1,195 | 0.819 | 0.764 | 1.40 (1.13, 1.72) | 0.0019 |
Netherlands | 515 | 769 | 0.828 | 0.809 | 1.13 (0.92, 1.39) | 0.23 |
IARCa | 2,506 | 1,914 | 0.763 | 0.778 | 1.10 (0.99, 1.22) | 0.072 |
Combined | 4,403 | 41,340 | - | - | 1.12 (1.05, 1.20) | 0.00060 |
rs215614-G, chromosome 7p14 | ||||||
Iceland | 839 | 36,606 | 0.366 | 0.355 | 1.05 (0.95, 1.16) | 0.37 |
Denver | 195 | 864 | 0.403 | 0.376 | 1.12 (0.89, 1.40) | 0.33 |
Spain | 450 | 1,281 | 0.370 | 0.335 | 1.17 (1.00, 1.37) | 0.055 |
Netherlands | 502 | 1,709 | 0.366 | 0.367 | 0.99 (0.86, 1.15) | 0.92 |
IARCa | 2,513 | 1,917 | 0.344 | 0.365 | 1.09 (1.00, 1.19) | 0.057 |
Combined | 4,499 | 42,377 | - | - | 1.07 (1.02, 1.13) | 0.011 |
rs7937-T, chromosome 19q13 | ||||||
Iceland | 836 | 36,552 | 0.555 | 0.549 | 1.03 (0.93, 1.13) | 0.60 |
Denver | 193 | 864 | 0.567 | 0.595 | 0.89 (0.71, 1.12) | 0.32 |
Spain | 453 | 1,330 | 0.532 | 0.512 | 1.08 (0.93, 1.26) | 0.31 |
Netherlands | 528 | 1,629 | 0.552 | 0.548 | 1.02 (0.89, 1.17) | 0.80 |
IARC | 2,518 | 1,921 | 0.559 | 0.580 | 1.09 (1.00, 1.18) | 0.048 |
Combined | 4,528 | 42,296 | - | - | 1.05 (0.99, 1.10) | 0.080 |
rs4105144-C, chromosome 19q13 | ||||||
Iceland | 839 | 36,606 | 0.713 | 0.705 | 1.04 (0.90, 1.20) | 0.61 |
Denver | 193 | 848 | 0.725 | 0.688 | 1.20 (0.94, 1.53) | 0.14 |
Spain | 437 | 1,288 | 0.669 | 0.620 | 1.24 (1.06, 1.46) | 0.0085 |
Netherlands | 513 | 1,665 | 0.638 | 0.640 | 0.99 (0.86, 1.15) | 0.93 |
Combined | 1,982 | 40,407 | - | - | 1.09 (1.00, 1.18) | 0.040 |
rs7260329-G, chromosome 19q13 | ||||||
Iceland | 831 | 36,454 | 0.688 | 0.669 | 1.09 (0.98, 1.21) | 0.11 |
Denver | 189 | 808 | 0.728 | 0.694 | 1.18 (0.92, 1.51) | 0.20 |
Spain | 457 | 1,305 | 0.702 | 0.674 | 1.14 (0.97, 1.35) | 0.11 |
Netherlands | 519 | 1,660 | 0.701 | 0.678 | 1.12 (0.96, 1.30) | 0.15 |
IARC | 2,481 | 1,899 | 0.662 | 0.670 | 1.02 (0.95, 1.10) | 0.61 |
Combined | 4,477 | 42,126 | - | - | 1.06 (1.00, 1.12) | 0.041 |
For IARC, results for rs6474412 and rs215614 were not available and here we report results for rs6474414 and rs215605, respectively, both of which are perfect surrogates in the HapMap CEU samples (r2=1).